Medihere has introduced the nation’s first telemedicine treatment application after the government temporarily allowed remote treatment amid the new coronavirus spread.
Medihere, a digital healthcare startup, said Tuesday that it would provide its Medihere-Remote Treatment Platform to medical institutions free of charge until the COVID-19 outbreak subsides. The company is searching for doctors and hospitals wanting to use its app for remote treatment.
Medihere said it developed the application to help prevent the virus from spreading by aiding patients who cannot visit hospitals due to the risk of COVID-19 infection.
The company would transfer the money to medical institutions' accounts for all the expenses caused by using the application such as quality remote communication solution, server cost, medical platform cost, brokerage, treatment cost, and medical expenses transfer fee, it added.
Doctor on Demand, a remote treatment platform startup, and other companies such as Lyft, Uber, Airbnb, Netflix, Twitter, Zendesk, Wix, Spotify, Yelp, Hulu, Morgan Stanley, ING, eBay, and Luluemon are using the application, it said.
|Clients’ evaluation of Twilio’s high-quality telecommunication solution using Medihere's app|
The patients can receive remote treatments in emergency medicine, internal medicine, pediatrics, ophthalmology, obstetrics, gynecology, skincare, respiratory disease, and psychiatry.
To receive the medical service, the patients have only to download the application and choose the field of medicine, doctor, and treatment method. The next step is to register symptoms and a credit card for treatment. Once the application is complete, the patient should input additional information necessary for medical care and pharmacy data to receive a prescription.
The practitioners can access the doctor's remote medical care Admin Website and set hospital information, treatment cost, and schedule through membership registration.
Doctors can check symptoms and data provided by the patients during the telemedicine service, and send the patient's prescription to the registered pharmacy.
"I believe Medihere's core function of telemedicine can overcome the limit of phone-treatment and provide more effective and correct communication between the patients and practitioners," Medihere CEO Kim Ki-hwan said. “Medihere plans to expand the free supply of its application to medical institutions and focus on promoting the app in Daegu and North Gyeongsang Province, hit hardest by the new coronavirus.”
<© Korea Biomedical Review, All rights reserved.>